Ctedwomen who used NVP-based highly active ART with CD4 counts higher than 350 cells/ .19 ART interruption exposes the HIV patient to risk of developing drug resistance. Proper use of antiretroviral therapy in HIV-1 infection enhances treatment outcomes and immunological recovery.LimitationsThe small sample size of pharmacies which were stocking ARVs is a limitation of this study. The study was co
Owed a direct correlation between microglial activation/infection and cognitive decline [19]. Studies have found microglial HIV infection as central in exacerbating HIV dementia [20,21]. Importantly, neuronal dysfunction and death in HIV infection results from cytokine stimulation, but especially several cytokine-mediated apoptotic mechanisms emanating from microglia. Thus microglial cytokine prod
Pectively, correspond to the type ii or iii microglial states described in the preceding paragraph. Further, the factors which cause polarization to M1 or M2, reinforce the maintenance of that phenotype in a cycle-like manner [8,9] (Figure 1). Increased M1 polarization is consistent with increased TNF-a observed in plasma and brain specimens in HAD and AD, and may play a role in the pathophysiolog
Molecules including major histocompatibility complex (MHC) II and CD40 [15]. Microglia expressing MHC II induce CD4+ T cells to generate IFN-g and TNF-a [16]. In the case of both HAD and AD, this response is considered harmful to the brain and in both diseases TNFa is elevated to neurotoxic levels while only in HAD is IFN-g is prominently elevated [14]. In HIV associated dementia (HAD; also known
Ctedwomen who used NVP-based highly active ART with CD4 counts higher than 350 cells/ .19 ART interruption exposes the HIV patient to risk of developing drug resistance. Proper use of antiretroviral therapy in HIV-1 infection enhances treatment outcomes and immunological recovery.LimitationsThe small sample size of pharmacies which were stocking ARVs is a limitation of this study. The study was co
Molecules including major histocompatibility complex (MHC) II and CD40 [15]. Microglia expressing MHC II induce CD4+ T cells to generate IFN-g and TNF-a [16]. In the case of both HAD and AD, this response is considered harmful to the brain and in both diseases TNFa is elevated to neurotoxic levels while only in HAD is IFN-g is prominently elevated [14]. In HIV associated dementia (HAD; also known
Ctedwomen who used NVP-based highly active ART with CD4 counts higher than 350 cells/ .19 ART interruption exposes the HIV patient to risk of developing drug resistance. Proper use of antiretroviral therapy in HIV-1 infection enhances treatment outcomes and immunological recovery.LimitationsThe small sample size of pharmacies which were stocking ARVs is a limitation of this study. The study was co
Sed tau (a component of the neurofibrillary tangle, a second AD neuropathological hallmark) have been proposed as sensitive and specific markers of AD in several studies [47,48]. It has also been found that changes in CSF Ab and tau are comparable to those observed in AD and HAD patients [49]. The pathogenic significance of these biomarkers is not well established but it has been hypothesized that
Sed tau (a component of the neurofibrillary tangle, a second AD neuropathological hallmark) have been proposed as sensitive and specific markers of AD in several studies [47,48]. It has also been found that changes in CSF Ab and tau are comparable to those observed in AD and HAD patients [49]. The pathogenic significance of these biomarkers is not well established but it has been hypothesized that
Addressing referee critiques. JS, AC, SR, and JJ were responsible for the initial literature search and first draft one of the review. DO contributed to the generation of Figure 1. JT provided review material for incorporation into the paper regarding the role of CD45 in neurodegeneration in the context of AD. FF provided clinical background regarding HIV and Alzheimer's-type dementias. All author